Skip to main navigation Skip to search Skip to main content

A class of hydrazones are active against nonreplicating Mycobacterium tuberculosis

  • Shilah A. Bonnett
  • , Devon Dennison
  • , Megan Files
  • , Anumita Bajpai
  • , Tanya Parish
  • Infectious Disease Research Institute

Research output: Contribution to journalArticlepeer-review

30 Citations (Scopus)

Abstract

There is an urgent need for the development of shorter, simpler and more tolerable drugs to treat antibiotic tolerant populations of Mycobacterium tuberculosis. We previously identified a series of hydrazones active against M. tuberculosis. We selected five representative compounds for further analysis. All compounds were active against non-replicating M. tuberculosis, with two compounds demonstrating greater activity under hypoxic conditions than aerobic culture. Compounds had bactericidal activity with MBC/MIC of < 4 and demonstrated an inoculum-dependent effect against aerobically replicating bacteria. Bacterial kill kinetics demonstrated a faster rate of kill against non-replicating bacilli generated by nutrient starvation. Compounds had limited activity against other bacterial species. In conclusion, we have demonstrated that hydrazones have some attractive properties in terms of their anti-tubercular activity.

Original languageEnglish
Article numbere0198059
JournalPLoS ONE
Volume13
Issue number10
DOIs
Publication statusPublished - 17 Oct 2018
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A class of hydrazones are active against nonreplicating Mycobacterium tuberculosis'. Together they form a unique fingerprint.

Cite this